Chow Eric J, Kamineni Aruna, Daling Janet R, Fraser Alison, Wiggins Charles L, Mineau Geraldine P, Hamre Merlin R, Severson Richard K, Drews-Botsch Carolyn, Mueller Beth A
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Arch Pediatr Adolesc Med. 2009 Oct;163(10):887-94. doi: 10.1001/archpediatrics.2009.111.
To compare the risk of reproductive and infant outcomes between male childhood cancer survivors and a population-based comparison group.
Retrospective cohort study.
Four US regions.
Cancer registries identified males younger than 20 years diagnosed with cancer from 1973 to 2000. Linked birth certificates identified first subsequent live offspring (N = 470). Comparison subjects were identified from remaining birth certificates, frequency-matched on year and age at fatherhood, and race/ethnicity (N = 4150).
Cancer diagnosis before age 20 years.
Pregnancy and infant outcomes identified from birth certificates.
Compared with infants born to unaffected males, offspring of cancer survivors had a borderline risk of having a birth weight less than 2500 g (relative risk, 1.43 [95% confidence interval, 0.99-2.05]) that was associated most strongly with younger age at cancer diagnosis and exposure to any chemotherapy (1.96 [1.22-3.17]) or radiotherapy (1.95 [1.14-3.35]). However, they were not at risk of being born prematurely, being small for gestational age, having malformations, or having an altered male to female ratio. Overall, female partners of male survivors were not more likely to have maternal complications recorded on birth records vs the comparison group. However, preeclampsia was associated with some cancers, especially central nervous system tumors (relative risk, 3.36 [95% confidence interval, 1.63-6.90]).
Most pregnancies resulting in live births among partners of male childhood cancer survivors were not at significantly greater risk of complications vs comparison subjects. However, there remains the possibility that prior cancer therapy may affect male germ cells with some effects on progeny and on female partners.
比较男性儿童癌症幸存者与基于人群的对照组在生殖及婴儿结局方面的风险。
回顾性队列研究。
美国四个地区。
癌症登记处确定了1973年至2000年期间诊断为癌症的20岁以下男性。关联的出生证明确定了其后的首个活产后代(N = 470)。对照对象从其余出生证明中确定,根据父亲生育时的年份和年龄以及种族/族裔进行频率匹配(N = 4150)。
20岁前的癌症诊断。
从出生证明中确定的妊娠和婴儿结局。
与未受影响男性的婴儿相比,癌症幸存者的后代出生体重低于2500 g的风险接近临界值(相对风险,1.43 [95%置信区间,0.99 - 2.05]),这与癌症诊断时年龄较小以及接受任何化疗(1.96 [1.22 - 3.17])或放疗(1.95 [1.14 - 3.35])的关联最为强烈。然而,他们没有早产、小于胎龄、畸形或出生性别比改变的风险。总体而言,男性幸存者的女性伴侣在出生记录上记录的孕产妇并发症并不比对照组更常见。然而,先兆子痫与某些癌症有关,尤其是中枢神经系统肿瘤(相对风险,3.36 [95%置信区间,1.63 - 6.90])。
与对照对象相比,男性儿童癌症幸存者的伴侣中大多数导致活产的妊娠并发症风险没有显著增加。然而,先前的癌症治疗仍有可能影响男性生殖细胞,对后代和女性伴侣产生一些影响。